Press Release

Global Cloning and Mutagenesis Market to Grow at a CAGR of 17% During 2024-2032, Aided by the Rising Prevalence of Chronic and Genetic Diseases

Global Cloning and Mutagenesis Market

According to a new report by EMR titled, ‘Global Cloning and Mutagenesis Market Report and Forecast 2024-2032’, the global market for cloning and mutagenesis is expected to grow at a CAGR of 17% in the forecast period of 2024-2032.

With the growing prevalence of various genetic and chronic diseases, cloning of genes is extensively used in the detection of such issues and in their treatment through methods like gene therapy. Hence, the rising cases of sickle cell anaemia and leukaemia, among others, are driving the cloning and mutagenesis market.

 

The increasing cloning of genes in the synthesis of antibiotics, hormones, and vitamins, among others, for the treatment of issues such as cystic fibrosis is propelling the market growth. The market growth can also be attributed to the rising use of cloning in supporting new discoveries for therapeutics, vaccine development, and various emerging synthetic biology applications. Furthermore, the increasing research activities to develop next-generation cloning for creating custom vectors for any application are likely to fuel the market growth.

 

The addition of cloning in various advanced systems by the leading companies is propelling the cloning and mutagenesis market. In May 2021, Codex DNA, Inc. (NASDAQ: DNAY) announced the addition of a longer fragment cloning to its BioXp™ system, which is a fully automated benchtop instrument facilitating various synthetic biology workflows. It would eliminate the requirement to manually synthesise error-corrected genes. 

 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The addition of longer fragment cloning would also enable scientists to produce multivariant, error-corrected, de novo synthetic genes up to 7.2 kilobase pairs (kb) in length. The cloning of them into custom vectors could be done overnight and hands-free by using the company’s Gibson Assembly technology. 

 

Moreover, the 7.2 kb length expands the use of the BioXp™ system to enable researchers to study proteins larger than human proteins. This would also boost the use of the system in various applications such as metabolic engineering, antibody engineering, small genome construction, and targeted gene variant analysis, among others.

 

Market Analysis by Product, Technique, End Use, and Region:

  • The cloning and mutagenesis market, on the basis of product, can be divided into cloning kits and mutagenesis kits.
  • Based on technique, the market can be divided into topo PCR cloning, blunt end cloning, seamless cloning, and site-directed mutagenesis, among others.
  • The major end uses of cloning and mutagenesis include biotechnology companies and academic and research institutes, among others.
  • The regional markets for cloning and mutagenesis include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Key Findings of the Report:

  • The growing prevalence of various genetic and chronic diseases and the rising demand for personalised medicines are augmenting the cloning and mutagenesis market growth.
  • The market is being propelled by the rising investments in research and development activities for the treatment of genetic diseases.
  • The robust growth of the biotechnology industry, the surging funding by various governmental organisations, and the advancements in cloning and mutagenesis technology are driving the market growth of cloning and mutagenesis.
  • The increasing cost-effectiveness of cloning and mutagenesis kits is invigorating the market growth.

 

Key Offerings of the Report: 

  • The EMR report gives an overview of the global cloning and mutagenesis market for the periods (2018-2023) and (2024-2032).
  • The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the products, techniques, end uses, and major regions of cloning and mutagenesis.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

 

The major players in the global cloning and mutagenesis market are Thermo Fisher Scientific Inc., Takara Bio Inc., Codex DNA, Inc., Agilent Technologies, Inc., and TransGen Biotech Co., Ltd., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

 

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

 

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

 

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER